Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2019

Open Access 01-12-2019 | Joint Pain | Case report

Antisynthetase syndrome presenting as interstitial lung disease: a case report

Authors: Aliena Badshah, Iqbal Haider, Shayan Pervez, Mohammad Humayun

Published in: Journal of Medical Case Reports | Issue 1/2019

Login to get access

Abstract

Background

Antisynthetase syndrome is a relatively uncommon entity, and can be easily missed if not specifically looked for in adults whose initial presentation is with interstitial lung disease. Its presentation with interstitial lung disease alters its prognosis.

Case presentation

This case report describes a 27-year-old Pakistani, Asian man, a medical student, with no previous comorbidities or significant family history who presented with a 3 months’ history of low grade fever and lower respiratory tract infections, associated with exertional dyspnea, arthralgias, and gradual weight loss. During these 3 months, he had received multiple orally administered antibiotics for suspected community-acquired pneumonia. When he presented to us, he was pale and febrile. A chest examination was significant for bi-basal end-inspiratory crackles. Preliminary investigations revealed raised erythrocyte sedimentation rate. High resolution computed tomography of his chest showed fine ground-glass attenuation in posterior basal segments of both lower lobes suggestive of interstitial lung disease. He was started on dexamethasone, to which he responded and showed improvement. However, during the course of events, he developed progressive proximal muscle weakness. Further investigations revealed raised creatinine phosphokinase and lactate dehydrogenase. A thorough autoimmune profile was carried out which showed positive anti-Jo-1 antibodies in high titers. A muscle biopsy was consistent with inflammatory myopathy. Clinical, radiological, serological, and histopathological markers aided in making the definitive diagnosis of antisynthetase syndrome. Antisynthetase syndrome is a variant of polymyositis but with visceral involvement, that is, interstitial lung disease and positive anti-Jo-1 antibodies. Our patient responded very well to glucocorticoids and azathioprine.

Conclusion

Antisynthetase syndrome is a rare clinical entity which apart from clinical presentation requires specific serological investigations for diagnosis. Concomitant association of interstitial lung disease gives it a guarded prognosis.
Literature
1.
go back to reference Trallero-Araguás E, et al. Clinical manifestations and long-term outcome of anti Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Semin Arthritis Rheum. 2016;16(30):1–4. Trallero-Araguás E, et al. Clinical manifestations and long-term outcome of anti Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Semin Arthritis Rheum. 2016;16(30):1–4.
2.
go back to reference Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med. 2007;28(4):451–8.CrossRef Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med. 2007;28(4):451–8.CrossRef
3.
go back to reference Mirrakhimov AE. Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. Curr Med Chem. 2015;22(16):1963–75.CrossRef Mirrakhimov AE. Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. Curr Med Chem. 2015;22(16):1963–75.CrossRef
4.
go back to reference Chatterjee S, Prayson R, Farver C. Antisynthetase syndrome: not just an inflammatory myopathy. Cleve Clin J Med. 2013;80(10):655–66.CrossRef Chatterjee S, Prayson R, Farver C. Antisynthetase syndrome: not just an inflammatory myopathy. Cleve Clin J Med. 2013;80(10):655–66.CrossRef
5.
go back to reference Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014;13:367–71.CrossRef Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014;13:367–71.CrossRef
6.
go back to reference Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23(8):881–8.CrossRef Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23(8):881–8.CrossRef
7.
go back to reference Bartoloni E, Gonzazlez-Gay MA, Scire C, et al. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: results from a multicenter, international and retrospective study. Autoimmune Rev. 2017;16:253–7.CrossRef Bartoloni E, Gonzazlez-Gay MA, Scire C, et al. Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: results from a multicenter, international and retrospective study. Autoimmune Rev. 2017;16:253–7.CrossRef
8.
go back to reference Solomon J, Swigris JJ, Brown K. Myositis related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100–9.CrossRef Solomon J, Swigris JJ, Brown K. Myositis related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100–9.CrossRef
9.
go back to reference Bergoin C, Bure M, Tavernier JY, Lamblin C, Maurage CA, Remy-Jardin M, Wallaert B. The anti-synthetase syndrome. Revue des Maladies Respiratoires (in French). 2002;19(3):371–4. Bergoin C, Bure M, Tavernier JY, Lamblin C, Maurage CA, Remy-Jardin M, Wallaert B. The anti-synthetase syndrome. Revue des Maladies Respiratoires (in French). 2002;19(3):371–4.
10.
go back to reference Gonzalez-Gay MA, Montecucco C, Selva-O’Callaghan A, et al. Timing of onset affects arthritis presentation pattern in antisynthetase syndrome. Clin Exp Rheumatol. 2018;36:44–9.PubMed Gonzalez-Gay MA, Montecucco C, Selva-O’Callaghan A, et al. Timing of onset affects arthritis presentation pattern in antisynthetase syndrome. Clin Exp Rheumatol. 2018;36:44–9.PubMed
11.
go back to reference Christopher-Stine L, et al. A man with fevers, arthrhalgias, and pulmonary infiltrates. NEJM. 2016;367:2134–47. Christopher-Stine L, et al. A man with fevers, arthrhalgias, and pulmonary infiltrates. NEJM. 2016;367:2134–47.
12.
go back to reference Noguchi E, Uruha A, Suzuki S, et al. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol. 2017;74:992–9.CrossRef Noguchi E, Uruha A, Suzuki S, et al. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol. 2017;74:992–9.CrossRef
13.
go back to reference Lazarou IN, Guerne PA. Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol. 2013;40(5):550–64.CrossRef Lazarou IN, Guerne PA. Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol. 2013;40(5):550–64.CrossRef
Metadata
Title
Antisynthetase syndrome presenting as interstitial lung disease: a case report
Authors
Aliena Badshah
Iqbal Haider
Shayan Pervez
Mohammad Humayun
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2019
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-019-2146-0

Other articles of this Issue 1/2019

Journal of Medical Case Reports 1/2019 Go to the issue